The prevalence of antibiotic resistant pathogens has become a crisis in the clinical setting. For new antibiotics to be developed, compounds with novel bacterial targets must be discovered. Here, it is demonstrated that the quinoline class of compounds has antibiotic activity by targeting the trans-translation pathway. It is shown that the compounds target a protease of clinical interest. Research into these compounds could lead to a new drug to aid in the fight against superbugs.